S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

HCM HUTCHMED China Limited

18.43

0.00 (0.00%)

Pre Market

Last Updated: 20:02:29

Delayed by 15 minutes

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Article too big to display. Click here to view on the SEC website

HUTCHMED China (NASDAQ:HCM)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more HUTCHMED China Charts.

HUTCHMED China (NASDAQ:HCM)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more HUTCHMED China Charts.

HUTCHMED China Limited News

HUTCHMED Announces Continued Inclusion of ORPATHYS® (savolitinib) in the National Reimbursement Drug List in China at Current Terms
Thursday 28 November 2024 (23 hours ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 22 November 2024 (7 days ago) • Edgar (US Regulatory)

HUTCHMED Announces Launch by Takeda of FRUZAQLA® (fruquintinib) in Japan
Friday 22 November 2024 (1 week ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 20 November 2024 (1 week ago) • Edgar (US Regulatory)

HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee
Wednesday 20 November 2024 (1 week ago) • GlobeNewswire Inc.

HUTCHMED Highlights Clinical Data to be Presented at the 2024 ASH Annual Meeting and the 2024 ESMO Asia Congress
Wednesday 6 November 2024 (3 weeks ago) • GlobeNewswire Inc.

HUTCHMED to Receive First Commercial Milestone Payment Following Over US$200 Million in FRUZAQLA® (fruquintinib) Sales by Takeda
Thursday 31 October 2024 (4 weeks ago) • GlobeNewswire Inc.

HUTCHMED Announces that TAGRISSO® plus ORPATHYS® demonstrated high, clinically meaningful response rate in lung cancer patients with high levels of MET overexpression and/or amplification in SAVANNAH Phase II trial
Wednesday 16 October 2024 (1 month ago) • GlobeNewswire Inc.

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
Thursday 26 September 2024 (2 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 24 September 2024 (2 months ago) • Edgar (US Regulatory)

HUTCHMED Announces Japan Approval for FRUZAQLA® (fruquintinib) Received by Takeda
Tuesday 24 September 2024 (2 months ago) • GlobeNewswire Inc.

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024
Wednesday 18 September 2024 (2 months ago) • GlobeNewswire Inc.

More HUTCHMED China Limited News Articles

Commonwealth Bank Of Aus...

AUD vs US Dollar

Australia And New Zealan...

Verizon Communications

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions